Uterine rupture secondary to undiagnosed placental site trophoblastic tumor: case report

ABSTRACT

Placental site trophoblastic tumor is a rare and malignant form of gestational trophoblastic disease. Its incidence rate is 1/50.000-100.000 pregnancies and accounts for less than 3% of all cases of gestational trophoblastic disease. In addition to its infrequency, the tumor lacks pathognomonic sonographic features, delaying diagnosis until immunohistochemical staining of uterine samples. Early diagnosis is key to avoid metastatic disease. We report a case of an undiagnosed placental site trophoblastic tumor, which caused uterine rupture and hemorrhagic shock.

Keywords:

immunohistochemistry - placental site trophoblastic tumor - transvaginal sonography

• REFERENCES

• 1 Lucas R, Cunha T M, Santos F B. Placental site trophoblastic tumor: a case report and review of the literature. J Radiol Case Rep 2015; 9 (04) 14-22
• 2 Brown J, Naumann R W, Seckl M J, Schink J. 15 years of progress in gestational trophoblastic disease: scoring, standardization, and salvage. Gynecol Oncol 2016; 144 (01) 200-207
• 3 De Nola R, Schönauer L M, Fiore M G, Loverro M, Carriero C, Di Naro E. Management of placental site trophoblastic tumor: two case reports. Medicine (Baltimore) 2018; 97 (48) 134-139
• 4 Gadducci A, Carinelli S, Guerrieri M E, Aletti G D. Placental site trophoblastic tumor and epithelioid trophoblastic tumor: clinical and pathological features.
• 5 Gynecol Oncol 2019; 153 (07) 684-693
• 6 Braga A, Sun SY, Maestá I, Uberti E. Doença trofoblástica gestacional. São Paulo: Federação Brasileira das Associações de Ginecologia e Obstetrícia (FEBRASGO); 2018. (Protocolo FEBRASGO - Obstetrícia, no 23/ Comissão Nacional Especializada em Doença Trofoblástica Gestacional).
• 7 Shaaban AM, Rezvani M, Haroun RR, Kennedy AM, Elsayes KM, Olpin JD, Salama ME, Foster BR, Menias CO. Gestational Trophoblastic Disease: Clinical and Imaging Features. RadioGraphics 2017; 37 (04) 681-700
• 8 Feng X, Wei Z, Zhang S, Du Y, Zhao H. A Review on the Pathogenesis and Clinical Management of Placental Site Trophoblastic Tumors. Front Oncol 2019; 9: 937-937
• 9 Santoro G, Laganà A.S, Micali A. et al. Historical, morphological and clinical overview of placental site trophoblastic tumors: from bench to bedside. Arch Gynecol Obstet 2017; 295: 173-187
• 10 Behtash N, Ghaemmaghami F, Hasanzadeh M. Long term remission of metastatic placental site trophoblastic tumor (PSTT): Case report and review of literature. World J Surg Onc 2005; 3: 34-34
• 11 Zhou Y, Lu H, Yu C, Tian Q, Lu W. Sonographic characteristics of placental site trophoblastic tumor. Ultrasound Obstet Gynecol 2012; 41 (06) 679-684
• 12 Ngan HYS, Secki MJ, Berkowitz RS. et al. Diagnosis and management of gestational trophoblastic disease: 2021 update. Int J Gynecol Obstet 2021; 155 (Suppl. 1) 86-93
• 13 Hancock BW, Tidy J. Placental site trophoblastic tumour and epithelioid trophoblastic tumour. Best Pract Res Clin Obstet Gynaecol 2021; 74: 131-148
• 14 Chaves M, Maia T, Cunha TM, Veiga VF. Placental site trophoblastic tumour: the rarest subtype of gestational trophoblastic disease. BMJ Case Rep 2020; 13 (10) e235756
• 15 Rey Valzacchi GM, Odetto D, Chacon CB, Wernicke A, Xiang Y. Placental site trophoblastic disease. Int J Gynecol Cancer 2020; 30 (01) 144-149
• 16 Luiza J W, Taylor S E, Gao F F, Edwards R P. Placental site trophoblastic tumor: Immunohistochemistry algorithm key to diagnosis and review of literature. Gynecol Oncol Case Rep 2013; 7: 13-15
• 17 Shih IM, Kurman RJ. Ki-67 labeling index in the differential diagnosis of exaggerated placental site, placental site trophoblastic tumor, and choriocarcinoma: a double immunohistochemical staining technique using Ki-67 and Mel-CAM antibodies. Hum Pathol 1998; 29 (01) 27-33